Sixty folks were laid off... Research and development was hit hard... This will sure give the company a temporary bump in profits, but it will cost us dearly in the long run... Get rid of experienced and knowledgeable folks so you can add more... —  read more 

seems the company gives up for new drug development, just focus on manufacturer.

Doing good

monoclonal antibodies used to be all the rage a while ago. that's not the case any more.